Purpose The addition of platinum agents to anthracycline and taxane-based chemotherapy
in early-stage triple negative breast cancer (TNBC) patients improves pathological complete …

Background Triple-negative breast cancer (TNBC), the subtype of breast cancer with the
highest mortality rate, shows clinical characteristics of high heterogeneity, aggressiveness …

Retinoid X receptor α (RXRα) is a nuclear receptor (NR) which functions as the primary
heterodimeric partner of other NRs including the peroxisome proliferator-activated receptor γ …

Background: Pegylated liposomal doxorubicin (PLD), epirubicin and pirarubicin are the
main anthracyclines widely used in China. PLD demonstrates therapeutic response …

Objective Hormone receptor (HR)-low/HER2-negative breast cancers (BCs) are more likely
to be basal-like BCs, with similar molecular features and gene expression profiles to HR …

Breast cancer (BC) is the most prevalent cancer in women in Latin America and the
Caribbean. We compiled real-world data (RWD) on the epidemiology, diagnosis, treatment …

Background Neoadjuvant therapy, which aims to achieve a pathological complete response
(pCR) for better overall survival (OS) has several advantages for patients with early breast …

Objective Triple-negative breast cancer is a subtype of aggressive breast cancer. Our aim is
to evaluate the effectiveness and safety of neoadjuvant treatment in early-stage triple …

Objetivo el cáncer de mama triple negativo es un subtipo agresivo de cáncer de mama.
Nuestro objetivo es evaluar la eficacia y seguridad del tratamiento neoadyuvante en el …

Retinoid X receptor α (RXRα) is a nuclear receptor (NR) which functions as the primary
heterodimeric partner of other NRs including the peroxisome proliferator-activated receptor γ …